Palisade Bio, Inc.

NASDAQ (USD): Palisade Bio, Inc. (PALI)

Last Price

2.49

Today's Change

+1.09 (77.85%)

Day's Change

2.37 - 3.30

Trading Volume

53,716,235

Overview

Market Cap

3 Million

Shares Outstanding

1 Million

Avg Volume

110,157

Avg Price (50 Days)

2.83

Avg Price (200 Days)

4.32

PE Ratio

-0.19

EPS

-13.26

Earnings Announcement

14-Mar-2025

Previous Close

1.40

Open

2.85

Day's Range

2.37 - 3.3

Year Range

1.38 - 22.35

Trading Volume

53,746,244

Price Change Highlight

1 Day Change

76.81%

5 Day Change

39.85%

1 Month Change

4.01%

3 Month Change

-33.64%

6 Month Change

-44.50%

Ytd Change

-71.48%

1 Year Change

-71.35%

3 Year Change

-99.83%

5 Year Change

-99.94%

10 Year Change

-100.00%

Max Change

-100.00%

News and Blogs
Latest Hottest Following

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Biotechnology

Description:

Palisade Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing oral therapies that target serious diseases associated with the breakdown of the mucosal barrier protecting the gastrointestinal tract. Its lead therapeutic candidate is LB1148, an oral liquid formulation of the digestive enzyme inhibitor that is intended to inhibit digestive enzyme activity and preserve gut integrity during intestinal stress resulting from reduced blood flow to the intestine, infections, or due to surgery. The company was founded in 2005 and is headquartered in Carlsbad, California.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment